+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Esophageal Cancer Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy), By Disease Indication (Adenocarcinomas, Gastrointestinal Stromal Tumors, Carcinoid Tumors, Squamous Cell Carcinoma, Others), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Homecare Settings, Specialty Centers) Companies, and Country Forecast, 2021 to 2034

Global Esophageal Cancer Drugs Market size is forecast to increase from $10.81 Billion in 2026 to $17.36 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007127
Pages: 215 Pages

Esomeprazole Market Size, Share and Growth Outlook, 2026: Analysis By Dosage Form (Tablets, Capsules, Powder for Oral Suspension, Intravenous Injection), By Strength (20 mg, 40 mg, Others), By Application (Gastroesophageal Reflux Disease , Stomach Ulcers, Others), By End User (Hospitals, Ambulatory Surgical Centers & Clinics) Companies, and Country Forecast, 2021 to 2034

Global Esomeprazole Market size is forecast to increase from $2.53 Billion in 2026 to $3.91 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007126
Pages: 227 Pages

Escherichia Coli Testing Market Size, Share and Growth Outlook, 2026: Analysis By Test (Clinical Testing , Environmental Testing , Rapid Biosensor-based Assays), By Sample Type (Water, Food & Beverage, Clinical Stool, Animal Feed & Livestock), By End User (Hospitals & Clinics, Diagnostic Laboratories, Water Utilities & Wastewater Treatment Plants, Food Processing Companies, Government & Public-Health Agencies) Companies, and Country Forecast, 2021 to 2034

Global Escherichia Coli Testing Market size is forecast to increase from $2.65 Billion in 2026 to $4.32 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007125
Pages: 222 Pages

Erythropoietin Stimulating Agents Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Continuous Erythropoietin Receptor Activators ), By Application (Anemia, Kidney Disorders, Cancer, HIV, Surgery), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Clinics, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Erythropoietin Stimulating Agents Market size is forecast to increase from $7.47 Billion in 2026 to $10.07 Billion in 2034 at a CAGR of 3.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007124
Pages: 223 Pages

Erythropoietin Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Recombinant Human Erythropoietin, Biosimilars, Long-Acting Erythropoietin), By Application (Anemia, Chemotherapy-Induced Anemia, Anemia due to HIV), By End User (Hospitals, Specialty Clinics, Home Care Settings, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Erythropoietin Drugs Market size is forecast to increase from $7.44 Billion in 2026 to $10.83 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007123
Pages: 224 Pages

Erleada Market Size, Share and Growth Outlook, 2026: Analysis By Product (Branded Erleada , Generic Apalutamide Formulations), By Clinical Indication (Non-Metastatic Castration-Resistant Prostate Cancer , Metastatic Castration-Sensitive Prostate Cancer , Metastatic Castration-Resistant Prostate Cancer ), By Therapy Configuration (Monotherapy , Combination Therapies ), By End-User Setting (Specialized Oncology Centers & Cancer Institutes, Multi-Specialty Hospitals, Ambulatory Care Centers), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies & Dedicated Oncology Dispensaries, Retail Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Erleada Market size is forecast to increase from $3.46 Billion in 2026 to $6.45 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007122
Pages: 225 Pages

Erectile Dysfunction Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Phosphodiesterase Type 5 , Prostaglandin Analogues, Centrally-Acting Agents, Nitric Oxide ), By Product Type (Viagra , Cialis , Levitra , Stendra , Zydena , Vitaros ), By Mode of Administration (Oral Tablets & Capsules, Oro-dispersible , Topical Gels & Transdermal Systems, Nasal Sprays, Intracavernosal Injections & Intra-urethral Suppositories), By Distribution Channel (Retail Pharmacies & Community Drugstores, Hospital Pharmacies, Online Pharmacies & Direct-to-Consumer) Companies, and Country Forecast, 2021 to 2034

Global Erectile Dysfunction Drugs Market size is forecast to increase from $3.65 Billion in 2026 to $6.56 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007121
Pages: 221 Pages

Erectile Dysfunction Devices Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Penile Implants , Vacuum Constriction Devices , Low-Intensity Extracorporeal Shockwave Therapy , Penile Constriction Rings & Tension Systems), By Modality (Non-Invasive Devices, Invasive ), By Cause of Dysfunction (Vascular Disorders, Neurological Disorders, Endocrine , Psychological , Post-Surgical Trauma), By Patient Age Group (Under 40 Years, 40–60 Years, Over 60 Years), By End-User (Hospitals & Acute Care Settings, Urology & Specialty Clinics, Ambulatory Surgical Centers , Home Care) Companies, and Country Forecast, 2021 to 2034

Global Erectile Dysfunction Devices Market size is forecast to increase from $2.07 Billion in 2026 to $4.19 Billion in 2034 at a CAGR of 9.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007120
Pages: 218 Pages

ERCP (Endoscopic Retrograde Cholangiopancreatography) Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Duodenoscopes, Endotherapy Devices , Visualization and Imaging Systems, Energy Devices, Accessories and Consumables), By Procedure Type (Biliary Sphincterotomy, Biliary Stenting, Pancreatic Duct Stenting, Biliary and Pancreatic Duct Dilatation, Lithotripsy), By Technology (Reusable Systems, Single-Use, Hybrid Systems), By Application (Biliary Disorders , Pancreatic Disorders ), By End-User (Hospitals, Ambulatory Surgery Centers , Specialty Gastroenterology Clinics) Companies, and Country Forecast, 2021 to 2034

Global ERCP (Endoscopic Retrograde Cholangiopancreatography) Market size is forecast to increase from $2.09 Billion in 2026 to $4.55 Billion in 2034 at a CAGR of 10.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007119
Pages: 223 Pages

Equine Supplement Products Market Size, Share and Growth Outlook, 2026: Analysis By Supplement Type (Proteins and Amino Acids, Vitamins, Minerals and Electrolytes, Enzymes and Probiotics, Herbal), By Application (Joint and Mobility Support, Performance and Energy Enhancement, Digestive Health, Skin, Coat, and Hoof Care, Anxiety and Behavioral Management), By Distribution Channel (Veterinary Hospital Pharmacies, Retail Pharmacies and Specialty Pet Stores, Online), By End-User (Performance, Recreational, Professional Breeders and Trainers) Companies, and Country Forecast, 2021 to 2034

Global Equine Supplement Products Market size is forecast to increase from $118.13 Million in 2026 to $171.89 Million in 2034 at a CAGR of 4.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007118
Pages: 214 Pages